| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.019 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |